Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

Kazuya Sakai, MD, Hideo Yagi, MD, Masaki Hayakawa, MD, Tatsuhiko Someya, PhD, Kaori Harada, PhD, Masanori Matsumoto, MD

Blood (2018) 132 (Supplement 1): 2522.

https://doi.org/10.1182/blood-2018-99-113948

Published: 2018

Journal Articles

A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Blood (2018) 132 (Supplement 1): 5320.

https://doi.org/10.1182/blood-2018-99-111649

Published: 2018

Journal Articles

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Study in Japan

Blood (2015) 126 (23): 4341.

https://doi.org/10.1182/blood.V126.23.4341.4341

Published: 2015

Journal Articles

A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Rachel K Wee, Hiroyuki Takamatsu, MD PhD, Ryoichi Murata, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Naoki Takezako, MD PhD, Shigeki Ito, MD PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, MD PhD, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, MD PhD, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2015) 126 (23): 1782.

https://doi.org/10.1182/blood.V126.23.1782.1782

Published: 2015

Journal Articles

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma

Hiroyuki Takamatsu, MD PhD, Ryoichi Murata, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Naoki Takezako, MD PhD, Shigeki Ito, MD, PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, MD PhD, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, MD PhD, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2014) 124 (21): 2003.

https://doi.org/10.1182/blood.V124.21.2003.2003

Published: 2014

Journal Articles

Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

Hideo Yagi, MD PhD, Masaki Hayakawa, MD, Naoko Yamaguchi, Keigo Yamashita, MD, Shigeki Taniguchi, MD PhD, Masanori Matsumoto, MD PhD, Kazuo Tsubaki, MD PhD, Yoshihiro Fujimura, MD PhD

Blood (2014) 124 (21): 2857.

https://doi.org/10.1182/blood.V124.21.2857.2857

Published: 2014

Journal Articles

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation

Kazuyoshi Ishii, MD MPH, PhD, Shosaku Nomura, MD PhD, Tomoki Ito, MD PhD, Yuta Katayama, MD PhD, Taiichi Kyo, MD, Shuichi Ota, MD PhD, Masanori Seki, MD PhD, Shigeru Chiba, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD, Takayuki Ikezoe, MD PhD, Hideo Yagi, MD PhD, Yoji Ishida, MD, PhD, Naohito Fujishima, MD PhD, Kenichi Sawada, MDPhD

Blood (2014) 124 (21): 5089.

https://doi.org/10.1182/blood.V124.21.5089.5089

Published: 2014

Journal Articles

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

Yumi Yoshii, MD, Masanori Matsumoto, MD PhD, Kurumatani Norio, MD PhD, Ayami Isonishi, BS, Masahito Uemura, MD PhD, Yuji Hori, PhD, Masaki Hayakawa, MD, Hideo Yagi, MD PhD, Charles L Bennett, MD PhD MPP, Yoshihiro Fujimura, MD PhD

Blood (2014) 124 (21): 4209.

https://doi.org/10.1182/blood.V124.21.4209.4209

Published: 2014

Journal Articles

Recombinant Thrombomodurin For The Treatment Of Transplantation-Associated Coagulopathy After Allogeneic Stem Cell Transplantation

Kazuyoshi Ishii, MD, MPH, PhD, Shosaku Nomura, MD, PhD, Tomoki Ito, MD, PhD, Yuta Katayama, MD, PhD, Taiichi Kyo, MD, Shuichi Ota, MD, PhD, Masanori Seki, MD, PhD, Shigeru Chiba, MD, PhD, Yoshinobu Maeda, M.D., Ph.D., Mitsune Tanimoto, MD, PhD, Takayuki Ikezoe, MD. PhD, Hideo Yagi, MD, PhD, Yoji Ishida, M.D., Ph.D., Naohito Fujishima, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2013) 122 (21): 5454.

https://doi.org/10.1182/blood.V122.21.5454.5454

Published: 2013

Journal Articles

Reduced-Dosage Of Three Drugs Combination Of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Is Suitable For Elderly Frail Patients With Multiple Myeloma

Hideo Yagi, MD, PhD, Ryosuke Fujiwara, M.D., Keigo Sano, M.D., Keiko Yamazaki, M.D., Hitoshi Hanamoto, M.D., Ph.D., Kazuo Tsubaki, MD, PhD

Blood (2013) 122 (21): 1963.

https://doi.org/10.1182/blood.V122.21.1963.1963

Published: 2013

Journal Articles

A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis

Yoshihiro Fujimura, MD, PhD, Yumi Yoshii, MD, Masanori Matsumoto, MD, PhD, Ayami Isonishi, BS, Masaki Hayakawa, MD, Yoko Yoshida, MS, Hideo Yagi, MD, PhD, Koichi Kokame, PhD, Toshiyuki Miyata, PhD

Blood (2013) 122 (21): 3545.

https://doi.org/10.1182/blood.V122.21.3545.3545

Published: 2013

Journal Articles

Atypical Hemolytic Uremic Syndrome In Japan Characterized By The Inhibitory Antibody-Based Hemolytic Assay and The Gene Analysis

Yoko Yoshida, MS, Xinping Fan, MD, Yoshifumi Ohyama, PhD, Tetsuro Kokubo, PhD, Masanori Matsumoto, MD, PhD, Hideo Yagi, MD, PhD, Hiroko Shirotani-Ikejima, PhD, Toshiyuki Miyata, PhD, Yoshihiro Fujimura, MD, PhD

Blood (2013) 122 (21): 2318.

https://doi.org/10.1182/blood.V122.21.2318.2318

Published: 2013

Journal Articles

HSCT-Associated Hepatic VOD Is Initiated With Preceding Appearance Of Unusually Large Von Willebrand Factor Multimers In Patient Plasmas

Masaki Hayakawa, MD, Masanori Matsumoto, MD, PhD, Yumi Yoshii, MD, Hideo Yagi, MD, PhD, Hiroshi Kimura, MD, PhD, Yoshihiro Fujimura, MD, PhD

Blood (2013) 122 (21): 3625.

https://doi.org/10.1182/blood.V122.21.3625.3625

Published: 2013

Journal Articles

Reduced-Dosage of Three Drugs Combination of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Retains High Response Rate with Less Toxicities in Elderly Patients with Multiple Myeloma

Hideo Yagi, MD, PhD, Ryosuke Fujiwara, M.D., Keigo Sano, M.D., Fujita Mariko, M.D., Takashi Iizuka, M.D., Keiko Yamazaki, M.D., Hitoshi Hanamoto, M.D., Ph.D., Kazuo Tubaki, M.D., Ph.D.

Blood (2012) 120 (21): 1865.

https://doi.org/10.1182/blood.V120.21.1865.1865

Published: 2012

Journal Articles

Characterization of Two Patient Groups with Acquired Idiopathic Thrombotic Thrombocytopenic Purpura, Defined by ADAMTS13 (n=195) and/or Classic Pentad (n=89).

Masanori Matsumoto, MD, Ayami Isonishi, BS, Seiji Kato, PhD, Hiromichi Ishizashi, PhD, Hideo Yagi, MD, Yoshihiro Fujimura, MD

Blood (2009) 114 (22): 3505.

https://doi.org/10.1182/blood.V114.22.3505.3505

Published: 2009

Journal Articles

Natural History of 33 Patients with Upshaw-Schulman Syndrome Has Revealed That All the Gravida Develop Thrombocytopenia, Often Followed by Thrombotic Microangiopathy with Stillbirth.

Blood (2007) 110 (11): 3211.

https://doi.org/10.1182/blood.V110.11.3211.3211

Published: 2007

Journal Articles

Increased Plasma VWF Antigen over Decreased ADAMTS13 Activity in Patients with Liver Cirrhosis: Relationship to Degree of Liver Disturbance and Clinical Features.

Masahito Uemura, MD, Seiji Kato, PhD, Masanori Matsumoto, MD, Hiromichi Ishizashi, PhD, Ayami Isonishi, Hisahide Hiura, PhD, Tomomi Matsuyama, MD, Hideo Yagi, MD, Masatoshi Ishikawa, MD, Masao Fujimoto, MD, Hideyuki Kojima, MD, Hitoshi Yoshiji, MD, Yoshihiro Fujimura, MD, Hiroshi Fukui, MD

Blood (2006) 108 (11): 1496.

https://doi.org/10.1182/blood.V108.11.1496.1496

Published: 2006

Journal Articles

Initial Laboratory Findings Useful for Predicting the Diagnosis of Chronic ITP: Results of a Multicenter Prospective Study.

Masataka Kuwana, MD, Yoshiyuki Kurata, MD, Kingo Fujimura, MD, Koji Fujisawa, MD, Hideo Wada, MD, Toshiro Nagasawa, MD, Shosaku Nomura, MD, Tetsuhito Kojima, MD, Hideo Yagi, MD, Yasuo Ikeda, MD

Blood (2004) 104 (11): 2061.

https://doi.org/10.1182/blood.V104.11.2061.2061

Published: 2004

Journal Articles

Heightened Proteolysis of Plasma ADAMTS13 Antigen in Patients with Thrombotic Thrombocytopenic Purpura.

Hideo Yagi, MD, Masanori Matsumoto, MD, Taka-aki Iwamoto, Hiromichi Ishizachi, MD, Hitomi Nishimura, Ayami Isonishi, Kenji Soejima, PhD, Tomohiro Nakagaki, PhD, Toshio Mori, PhD, Yoshihiro Fujimura, MD

Blood (2004) 104 (11): 3946.

https://doi.org/10.1182/blood.V104.11.3946.3946

Published: 2004

NARROW

Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Study in Japan

A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma

Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

Recombinant Thrombomodurin For The Treatment Of Transplantation-Associated Coagulopathy After Allogeneic Stem Cell Transplantation

Reduced-Dosage Of Three Drugs Combination Of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Is Suitable For Elderly Frail Patients With Multiple Myeloma

A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis

Atypical Hemolytic Uremic Syndrome In Japan Characterized By The Inhibitory Antibody-Based Hemolytic Assay and The Gene Analysis

HSCT-Associated Hepatic VOD Is Initiated With Preceding Appearance Of Unusually Large Von Willebrand Factor Multimers In Patient Plasmas

Reduced-Dosage of Three Drugs Combination of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Retains High Response Rate with Less Toxicities in Elderly Patients with Multiple Myeloma

Characterization of Two Patient Groups with Acquired Idiopathic Thrombotic Thrombocytopenic Purpura, Defined by ADAMTS13 (n=195) and/or Classic Pentad (n=89).

Natural History of 33 Patients with Upshaw-Schulman Syndrome Has Revealed That All the Gravida Develop Thrombocytopenia, Often Followed by Thrombotic Microangiopathy with Stillbirth.

Increased Plasma VWF Antigen over Decreased ADAMTS13 Activity in Patients with Liver Cirrhosis: Relationship to Degree of Liver Disturbance and Clinical Features.

Initial Laboratory Findings Useful for Predicting the Diagnosis of Chronic ITP: Results of a Multicenter Prospective Study.

Heightened Proteolysis of Plasma ADAMTS13 Antigen in Patients with Thrombotic Thrombocytopenic Purpura.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only